Go to deals
Healthcare

Rice Steele has been acquired by Phoenix Labs

The shareholders of Rice Steele Manufacturing Ltd. have sold the business to Phoenix Labs.

Rice Steele Manufacturing is one of Ireland’s leading indigenous manufacturers of over-the-counter (OTC) medicinal and lifestyle products, including Dozol, pharmacy branded products, Paralink Solution, Rescofer iron tonics, and Pedamed powder and foot care products. The company offers a comprehensive range of over 65 OTC and prescription preparations in areas such as childcare analgesics, vitamins and minerals, footcare and sports care. It sells and distributes OTC products to customers in Ireland and exports to the UK, West Africa, the Caribbean and Iraq.

Phoenix Labs is an integrated healthcare company operating in the prescription and OTC market segments in Ireland and the UK. Its products are marketed around the world in countries including Australia, New Zealand, Spain, Italy, France, Czech Republic, Slovakia, Netherlands and Portugal.

Oaklins’ team in Ireland advised the seller in this transaction.

Service
M&A sell-side
Parties
“The team must be commended for their efficiency and performance in closing the deal on behalf of Rice Steele. They remained clear in their objectives and goals and guided us through the sale process from start to finish, in a COVID-19 environment that proved ever challenging.”

Bernard McCormick

Managing Director, Rice Steele Manufacturing Ltd.

Talk to the deal team

 Raymond  Donegan

Raymond Donegan

Managing Director

Dublin, Ireland
Oaklins IBI

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more
Biosynex has acquired Para’kito
Healthcare

Biosynex has acquired Para’kito

Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.

Learn more